Seminars in Arthritis and Rheumatism
Volume 40, Issue 3 , Pages 215-221, December 2010

Comparison of Symptoms, Treatment, and Outcomes of Coronary Artery Disease among Rheumatoid Arthritis and Matched Subjects Undergoing Percutaneous Coronary Intervention

  • Sonali P. Desai, MD

      Affiliations

    • Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA
    • Corresponding Author InformationAddress reprint requests to Sonali Parekh Desai, MD, Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, 75 Francis Street, PBB-B3, Boston, MA 02115
  • ,
  • James L. Januzzi, MD

      Affiliations

    • Division of Cardiology, Massachusetts General Hospital, Boston, MA
  • ,
  • Ashvin N. Pande, MD

      Affiliations

    • Division of Cardiology, Boston Medical Center, Boston, MA
  • ,
  • Eugene V. Pomerantsev, MD, PhD

      Affiliations

    • Division of Cardiology, Massachusetts General Hospital, Boston, MA
  • ,
  • Frederic S. Resnic, MD, MSc

      Affiliations

    • Division of Cardiology, Brigham & Women's Hospital, Boston, MA
  • ,
  • Anne Fossel

      Affiliations

    • Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA
  • ,
  • Lori B. Chibnik, PhD

      Affiliations

    • Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA
  • ,
  • Daniel H. Solomon, MD, MPH

      Affiliations

    • Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA

published online 14 June 2010.

Objective

Rheumatoid arthritis (RA) is associated with an increased prevalence of coronary artery disease (CAD). We investigated the presenting symptoms of CAD, coronary anatomy (single versus multi-vessel CAD), and treatment among a group of subjects undergoing percutaneous coronary intervention (PCI) with angioplasty and/or stenting.

Methods

We evaluated a retrospective cohort of 43 RA subjects and 43 matched non-RA subjects undergoing PCI at 2 academic referral centers. RA subjects were matched to non-RA subjects on age, gender, history of coronary artery bypass grafting, date of PCI, and interventional cardiologist. We compared cardiac risk factors, presentation, treatment, and outcomes.

Results

The mean age of the study cohort was 71 ± 10 years, and the distribution of traditional cardiac risk factors was similar in the subjects with RA compared with the matched non-RA subjects (all P values > 0.05). Seventy-four percent of subjects with RA compared with 67% of those without RA presented with an acute coronary syndrome before PCI (P = 0.48). All subjects in this cohort undergoing PCI had at least 1 stenosis in a major epicardial vessel and similar percentages of subjects with RA (44%) and without RA (40%) had multi-vessel CAD (P = 0.66). The administration of cardiac medications both at PCI and at hospital discharge was not different among subjects with RA compared with matched non-RA subjects.

Conclusions

Among this cohort with significant CAD undergoing PCI, clinical characteristics, presentation, severity of CAD, treatment modalities, and outcomes were similar in subjects with RA and well-matched non-RA subjects.

Keywords: rheumatoid arthritis, coronary artery disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Desai's efforts are supported by the NIH (T32 AR007530, Institutional Training Grant) and the American College of Rheumatology Research and Education Fund Physician Scientist Development Award. Dr. Solomon is supported by NIH Grants AR 055989 and AR 0477820, the Arthritis Foundation, and an AHRQ DECiDE Center Award.

PII: S0049-0172(10)00072-7

doi:10.1016/j.semarthrit.2010.04.002

Seminars in Arthritis and Rheumatism
Volume 40, Issue 3 , Pages 215-221, December 2010